Why should infectious disease physicians care for the hepatitis C-infected patient?

Eliot Godofsky1

  • 1University Hepatitis Center, 6010 Pointe West Boulevard, Bradenton, FL 32409, USA. egodofsky@gmail.com

Insights

Infectious disease (ID) physicians are crucial for managing Hepatitis C virus (HCV) infection, a significant public health issue. Increased ID physician involvement is vital for patient care, especially for those coinfected with HIV.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a major global health concern.
  • Effective management requires comprehensive strategies including screening, education, and transmission reduction.
  • Co-infection with human immunodeficiency virus (HIV) presents unique challenges in HCV care.

Purpose of the Study:

  • To highlight the essential role of infectious disease (ID) physicians in managing Hepatitis C virus (HCV).
  • To emphasize the need for increased ID physician involvement in HCV patient care, particularly for those coinfected with HIV.
  • To underscore the growing opportunity for ID physicians to lead HCV treatment in the era of direct-acting antivirals.

Main Methods:

  • This study is a review and expert opinion piece.
  • It synthesizes current understanding of HCV epidemiology and treatment landscapes.
  • It discusses the evolving role of ID specialists in public health infectious disease management.

Main Results:

  • HCV infection necessitates greater engagement from infectious disease (ID) physicians.
  • ID physicians are critical for addressing the complexities of HCV/HIV co-infection.
  • There is a growing demand for specialized provider resources in HCV care.

Conclusions:

  • The advent of direct-acting antivirals (DAAs) presents a significant opportunity for ID physicians to take a leading role in HCV management.
  • Enhanced involvement of ID physicians is crucial for improving patient outcomes and public health strategies related to HCV.
  • Specialized expertise from ID physicians is essential for optimizing care pathways and addressing health disparities in HCV patients.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...